Subverted macrophages in the triple-negative breast cancer ecosystem

被引:6
|
作者
Shang, Linxiao [1 ]
Zhong, Yuting [2 ]
Yao, Yan [2 ]
Liu, Cun [3 ]
Wang, Lu [4 ]
Zhang, Wenfeng [5 ]
Liu, Jingyang [2 ]
Wang, Xue [4 ]
Sun, Changgang [6 ,7 ]
机构
[1] Binzhou Med Univ, Sch Integrated Tradit Chinese & Western Med, Yantai 264000, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250022, Peoples R China
[3] Weifang Med Univ, Coll Tradit Chinese Med, Weifang 261000, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250022, Peoples R China
[5] Macau Univ Sci & Technol, Sch Tradit Chinese Med, Macau 999078, Peoples R China
[6] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261000, Peoples R China
[7] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor -associated macrophage; Triple-negative breast cancer; Target; Immunosuppression; Subvert; TUMOR-ASSOCIATED MACROPHAGES; MONOCLONAL-ANTIBODY THERAPY; CHECKPOINT BLOCKADE; CELLS; MICROENVIRONMENT; POLARIZATION; RESISTANCE; RECEPTOR; NANOPARTICLES; PHAGOCYTOSIS;
D O I
10.1016/j.biopha.2023.115414
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are the most critical effector cells of innate immunity and the most abundant tumor-infiltrating immune cells. They play a key role in the clearance of apoptotic bodies, regulation of inflammation, and tissue repair to maintain homeostasis in vivo. With the progression of triple-negative breast cancer(TNBC), TAMs are "subverted" from tumor-promoting immune cells to tumor-promoting immune suppressor cells, which play a significant role in tumor development and are considered potential targets for cancer therapy. Here, we explored how macrophages, as the most important part of the TNBC ecosystem, are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis. Similarly, we discuss the rationale and available evidence for TAMs as potential targets for TNBC therapy.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Morphotypes of the triple-negative breast cancer
    Koleckova, M.
    Kolar, Z.
    Ehrmann, J.
    Korinkova, G.
    Trojanec, R.
    VIRCHOWS ARCHIV, 2017, 471 : S296 - S296
  • [22] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [23] Targeting triple-negative breast cancer
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2009, 8 : 21 - 21
  • [24] Chemoimmunotherapy for Triple-Negative Breast Cancer
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2521 - 2521
  • [25] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [26] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204
  • [27] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [28] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [29] An overview of triple-negative breast cancer
    Pankaj Kumar
    Rupali Aggarwal
    Archives of Gynecology and Obstetrics, 2016, 293 : 247 - 269
  • [30] Triple-negative breast cancer in the elderly
    Shagisultanova, Elena
    Mayordomo, Jose
    Elias, Anthony D.
    BREAST JOURNAL, 2017, 23 (06): : 627 - 629